Optimized cocktail therapy in primary unilateral total hip arthroplasty with enhanced recovery after surgery program:a prospective randomized controlled trial

Shao-yun ZHANG,Qiang HUANG,Guo-rui CAO,Yi-ting LEI,Guo CHEN,Fu-xing PEI

DOI: https://doi.org/10.3969/j.issn.2095-252X.2017.12.002

2017-01-01

Abstract:Objective To explore the safety and efficacy of the optimized cocktail therapy [ local injection of ropivacaine with tranexamic acid ( TXA ) before incision closure ] in primary unilateral total hip arthroplasty ( THA ) with enhanced recovery after surgery ( ERAS ) program. Methods A total of 80 patients who underwent primary unilateral THA with ERAS program were randomly divided into the experimental group ( 40 patients ) that received local injection of 200 mg ropivacaine with 80 ml TXA before incision closure, and control group ( 40 patients ) that received local injection of 200 mg ropivacaine with 80 ml normal saline relatively. The maximum hemoglobin ( Hb ) drop, total blood loss, transfusion, visual analogue scale ( VAS ) pain score, the incidence for rescue analgesia, postoperative complications, length of stay, and embolism events during 2 weeks' follow-up were recorded and compared. Results In the experimental group, the maximum Hb drop was ( 24.3 ± 9.9 ) g / L, total blood loss was ( 737.4 ± 399.0 ) ml, which were not statistically significantly different from that in the control group ( 24.1 ± 10.9 ) g / L, ( 730.1 ± 401.3 ) ml ( P > 0.05 ). VAS pain score in mobilization preoperatively, on the day of surgery, and on postoperative day 1 and 3 in the experimental group were respectively on average ( 4.5 ± 0.7 ), ( 1.7 ± 0.5 ), ( 1.6 ± 0.6 ) and ( 1.2 ± 0.4 ), while in the control group were ( 4.5 ± 0.7 ), ( 1.5 ± 0.5 ), ( 1.6 ± 0.6 ) and ( 1.1 ± 0.4 ). VAS pain scores at each time points were not statistically significantly different between the 2 groups ( P > 0.05 ). The incidence for rescue analgesia and the rate of postoperative complications in the experimental group were 12.5% and 10.0%, while that were 7.5% and 17.5% in the control group. The differences were not statistically significant ( P > 0.05 ). There were no statistically significantly differences in postoperative length of stay [ ( 2.5 ± 0.6 ) days vs. ( 2.4 ± 0.7 ) days, P > 0.05 ]. No patients received transfusion and no deep vein thrombosis occurred 2 weeks after the surgery in either group. Conclusions Primary unilateral THA can reduce blood loss, cause less pain and achieve faster recovery with the implementation of ERAS program. There were no further reduction for the optimized cocktail therapy in perioperative blood loss and postoperative pain. However, it doesn't increase the incidence of postoperative complications and embolism events.